Is a complete FRA/RXK3 research report available?

No complete published report is available for fra/RXK3 (FRA/RXK3) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/RXK3 (FRA/RXK3)

Frankfurt Stock Exchange: FRA/RXK3 · EUR

€9.02

-0.18 (-2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/RXK3 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.7B
Net income (ttm)	-25.5M
EPS (ttm)	-€0.20
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -25.5M
EPS (ttm): -€0.20
Market cap: 1.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All FRA/RXK3 indicators

Market & fundamental data

Available fields

136

Groups with data

Currency

USD

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	13
Employees Change	-2%
Employees Change Percent	-13.33
Enterprise value	EUR 1.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 1.7B
Price	EUR 9.02
Price currency	EUR
Sic	2836
Symbol	fra/RXK3
Website	https://sellaslifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.46%
FCF yield	-1.4%
P/B ratio	18.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -25.5M
Profit Per Employee	EUR -2M
ROA	-25.45
Roa5y	-96.21
ROCE	-28.19
ROE	-43.58
ROIC	-27.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	512.46%
Cagr3y	87.73%
Cagr5y	5.28%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 99M
Cash	EUR 92.9M
Current Assets	EUR 96.4M
Current Liabilities	EUR 5.6M
Debt	EUR 755,418
Debt Equity	EUR 0.01
Debt FCF	EUR -0.03
Equity	EUR 93.2M
Liabilities	EUR 5.9M
Long Term Assets	EUR 2.6M
Long Term Liabilities	EUR 267,247
Net Cash	EUR 92.1M
Net Cash By Market Cap	EUR 5.28
Net Cash Growth	285.9%
Net Debt Equity	EUR -0.99
Tangible Book Value	EUR 91.5M
Tangible Book Value Per Share	EUR 0.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.22
Net Working Capital	EUR -1.6M
Quick ratio	16.59
Working Capital	EUR 90.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-81.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	511.7%
200-day SMA	4.64
3Y total return	561.87%
50-day SMA	9.08
50-day SMA vs 200-day SMA	50over200
5Y total return	29.3%
All Time High	435
All Time High Change	-97.89%
All Time High Date	2018-04-03
All Time Low	0.45
All Time Low Change	1,944.44%
All Time Low Date	2024-01-12
ATR	0.72
Ch YTD	228.6
High	9.02
High52	14.95
High52 Date	2026-06-30
High52ch	-39.67%
Low	8.62
Low52	1.2
Low52 Date	2025-11-18
Low52ch	650.42%
Ma50ch	1.33%
Price vs 200-day SMA	98.19%
RSI	44.14
RSI Monthly	64.94
RSI Weekly	61.18
Sharpe ratio	2.12x
Sortino ratio	4.07
Total Return	-81.03%
Tr YTD	228.6
Tr1m	-13.21%
Tr1w	-17.86%
Tr3m	123.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -26.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	195,835,143%
Shares Insiders	0.41%
Shares Institutions	27.66%
Shares Qo Q	22.1%
Shares Yo Y	81.03%
Short Ratio	5.73

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -26.4M
Adjusted OCF	-26,381,590.2
Average Volume	1,178.75x
Bv Per Share	0.51
Ch1m	-13.21
Ch1w	-17.86
Ch1y	511.7
Ch3m	123.8
Ch3y	561.9
Ch5y	29.3
Ch6m	158.4
Change	-1.96%
Change From Open	4.64
Close	9.2
Days Gap	-6.3
Earnings Date	2026-08-10
EBIT	EUR -26.3M
EPS	EUR -0.2
F Score	2
FCF	EUR -24.4M
FCF EV Yield	-1.48x
Financing CF	92,684,015
Fiscal Year End	December
Goodwill	1,660,234.2
Is Primary Listing	0
Last Report Date	2026-03-31
Last Split Date	2019-11-08
Last Split Type	Reverse
Ma150	5.68
Ma150ch	62.06%
Ma20	11.08
Ma20ch	-17%
Net CF	68,256,510
Next Earnings Date	2026-08-10
Open	8.62
Position In Range	100
Ppne	727,762
Price Date	2026-07-30
Ptbv Ratio	19.07
Relative Volume	0.88x
Share Based Comp	1,950,558
Tr6m	158.43%
Volume	0

FRA/RXK3 (FRA/RXK3)

Coverage state: Market snapshot only — no published research

Generate the first FRA/RXK3 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/RXK3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/RXK3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/RXK3

Frequently asked questions